Ces radiol. 2010, 64(2):158-165

N-Acetylcysteine in animals with intact kidney and induced renal injury in concept of contrast-induced nephropathy: acute experiment in ratsOriginal article

Jan Šochman1, Jan H. Peregrin2, Luděk Kopkan3, Marcela Bürgelová4, Luděk Červenka3
1 Klinika kardiologie IKEM, Praha
2 Základna radiodiagnostiky a intervenční radiologie IKEM, Praha
3 Pracoviště experimentální medicíny IKEM, Praha
4 Klinika nefrologie a Transplantcentrum IKEM, Praha

Aim: So far there is no evidence confirming effect of N-Acetylcysteine (NAC) administration on renal functions in various types of kidney-injured animals mimicking human conditions. Even in elementary interaction between NAC and iodinated contrast agents in terms of contrast-induced nephropathy (CIN) without graded kidney insult the literature does not reveal a consistent view. Our aim was to evaluate NAC protective effect in animal experiment.

Method: A total number of 139 rats were divided into 3 groups: Group I (n = 42) involved intact animals with no insult, Group II (n = 55) consisted of animals with subtotal nephrectomy, and Group III (n = 42) were animals with subtotal nephrectomy and further 12-hour long water intake restriction. Each of above groups was divided into 6 individual subgroups as follows: control subgroup without any pharmacology intervention, NAC subgroup was given NAC 100 mg/kg b.w., MIO subgroup received meglumine ioxatalamate 6 ml/kg b.w., while IOH subgroup was administered iohexol 6 ml/kg b.w. In the remaining 2 subgroups, a combination of contrast agent plus NAC was administered (MIO + NAC, and IOH + NAC). Plasma creatinine as well as creatinine clearance was measured before any agent administration, and 1, 3, and 7 days later for further evaluation.

Results: NAC administration improved creatinine-derived parameters (plasma creatinine concentration and clearance as well) on the first day after iodine contrast agent administration (p < 0.05) and attenuated negative impact of such contrast agents between day 1 to 7 in comparison to subgroups without NAC administration in various types of kidney injury.

Conclusion: NAC significantly improved creatinine-derived parameters in terms of various types of kidney insult.

Keywords: N-Acetylcysteine, iodine contrast agents, angiography, nephropathy

Accepted: April 15, 2010; Published: June 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šochman J, Peregrin JH, Kopkan L, Bürgelová M, Červenka L. N-Acetylcysteine in animals with intact kidney and induced renal injury in concept of contrast-induced nephropathy: acute experiment in rats. Ces radiol. 2010;64(2):158-165.
Download citation

References

  1. Friedewald VE, Goldfarb S, Laskey WK, McCullough PA, Roberts WC. The editor's roundtable: contrast-induced nephropathy. Amer J Cardiol 2007; 100: 544-551. Go to original source... Go to PubMed...
  2. Yoshimasa Y, Fogo A, Beltman JK. Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion. Kidney Int 1992; 41: 1008-1015. Go to original source... Go to PubMed...
  3. Russo D, Minutolo R, Cianciaruso B, Memoli B, Conte G, De Nicola L. Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 1995; 6: 1451-1458. Go to original source... Go to PubMed...
  4. Brezis M, Heyman SN, Epstein FH. Determinants of intrarenal oxygenation. II. Haemodynamic effects. Am J Physiol 1994; 267: 1063-1068. Go to original source... Go to PubMed...
  5. Heyman SN, Brezis M, Epstein FH, Spokes K, Silva P, Rosen S. Early medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int 1991; 40: 632-642. Go to original source... Go to PubMed...
  6. Agmon Y, Peleg H, Greenfeld Z, Rosen S, Brezis M. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 1994; 94: 1069-1075. Go to original source... Go to PubMed...
  7. Cantley LG, Spokes K, Clark BA, McMahon EG, Carter J, Epstein FH. Role of endotelin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney Int 1993; 44: 1217-1223. Go to original source... Go to PubMed...
  8. Solomon RC. Contrast-medium-induced acute renal failure. Kidney Int 1998; 53: 230-242. Go to original source... Go to PubMed...
  9. Weisberg LS, Kurnik PB, Kurnik BR. Radiocontrast-induced nephropathy in humans. Role of renal vasoconstriction. Kidney Int 1992; 41: 1408-1415. Go to original source... Go to PubMed...
  10. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. The Iohexol Cooperative Study. Kidney Int 1995; 47: 254-261. Go to original source... Go to PubMed...
  11. Dangas G, Iakovou I, Nikolsky E, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005; 95: 13-19. Go to original source... Go to PubMed...
  12. Nikolsky E, Mehran R, Turcot D, et al. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 2004; 94: 300-305. Go to original source... Go to PubMed...
  13. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and risk of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305. Go to original source... Go to PubMed...
  14. McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 2006; 98: 5K-13K. Go to original source... Go to PubMed...
  15. McCullough PA, Adam A, Becker CR, et al. Risk prediction of contrast-induced nephropathy. Am J Cardiol 2006; 98: 27K-36K. Go to original source... Go to PubMed...
  16. Nash K, Hafez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39: 930-936. Go to original source... Go to PubMed...
  17. Davidson CJ, Hlatky M, Morris KG, et al. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. Ann Int Med 1989; 110: 119-124. Go to original source... Go to PubMed...
  18. Katholi RE, Taylor GJ, McCann WP, et al. Nephrotoxicity from contrast media. Attenuation with theophylline. Radiology 1995; 195: 7-22. Go to original source... Go to PubMed...
  19. Manske CL, Sprafka JM, Strony JT, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990; 89: 615-620. Go to original source... Go to PubMed...
  20. Nunez BD, Allon M. Effect of cardiac catheterization on renal function. Clin Nephrol 1990; 34: 263-266.
  21. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced-renal failure in patients with diabetes mellitus, renal insufficiency, or both. N Engl J Med 1989; 320: 143-149. Go to original source... Go to PubMed...
  22. Di Mari J, Megyesi J, Udvarhelyi N, Price P, Davis R, Safirstein R, et al. N-acetylcysteine ameliorates ischemic renal failure. Am J Physiol 1997; 272: F292-F298. Go to original source... Go to PubMed...
  23. Šochman J, Kolc J, Vrána M, Fabián J. Cardioprotective effects of N-acetylcysteine: the reduction in the extent of infarction and occurrence of reperfusion arrhythmias in the dog. Int J Cardiol 1990; 28: 191-196. Go to original source... Go to PubMed...
  24. Šochman J, Vrbská J, Musilová B, Roček M. Infarct size limitation: acute N-acetylcysteine defense (ISLAND trial). Preliminary analysis and report after the first 30 patients. Clin Cardiol 1996; 19: 94-100. Go to original source... Go to PubMed...
  25. Šochman J. N-acetylcysteine in acute cardiology: 10 years later. What do we know and what would we like to know? J Am Coll Cardiol 2002; 39: 1422-1428. Go to original source... Go to PubMed...
  26. Šochman J, Krížová B. Prevention of contrast agent-induced renal impairment in patients with chronic renal insufficiency and heart disease by N-acetylcysteine in high intravenous dose: A pilot-ministudy. Kardiologia Polska 2006; 64: 559-563.
  27. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180-184. Go to original source... Go to PubMed...
  28. Tepel M, van der Giet M, Statz M, Jankowski J, Zidek W. The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial. Circulation 2003; 107: 992-995. Go to original source... Go to PubMed...
  29. Tepel M, Zidek W. N-acetylcysteine in nephrology; contrast nephropathy beyond. Curr Opinion Nephrol Hypertens 2004; 13: 649-654. Go to original source... Go to PubMed...
  30. Durham JD, Caputo C, Dokko J, et al. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int 2002; 62: 2202-2207. Go to original source... Go to PubMed...
  31. Fishbane S, Durham JH, Marzo K, Rudnick M. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol 2004; 15: 251-260. Go to original source... Go to PubMed...
  32. Shyu KG, Cheng JJ, Kuan P. N-acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 2002; 40: 1383-1388. Go to original source... Go to PubMed...
  33. Thomsen HS. Contrast-medium induced nephrotoxicity: Are all answers for acetylcysteine? Eur Radiol 2001; 11: 2351-2353. Go to original source... Go to PubMed...
  34. Hoffmann U, Banas B, Fischereder M, Kramer BK. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy: clinical trials and end points. Kidney Blood Press Res 2004; 27: 161-166. Go to original source... Go to PubMed...
  35. Hoffmann U, Fischereder M, Kruger B, Drobnik W, Kramer BK. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 2004; 15: 407-410. Go to original source... Go to PubMed...
  36. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW. Acetylcysteine to prevent angiography-related renal tissue injury. (The APART trial). Am J Cardiol 2002; 89: 356-358. Go to original source... Go to PubMed...
  37. Kandzari DE, Rebeiz AG, Wang A, Sketch MH, Jr. Contrast nephropathy: an evidence-based approach to prevention. Am J Cardiovasc Drugs 2003; 3: 395-405. Go to original source... Go to PubMed...
  38. Kay J, Chow WH, Chan TM, et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and interventions: A randomized controlled trial. JAMA 2003; 289: 553-558. Go to original source... Go to PubMed...
  39. Briguori C, Colombo A, Violante A, et al. Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J 2004; 25: 206-211. Go to original source... Go to PubMed...
  40. Briguori C, Manganelli F, Scarpato P, et al. Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol 2002; 40: 298-303. Go to original source... Go to PubMed...
  41. Alonso A, Lau J, Jaber BL, Weintraub A, Sarnak MJ. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. Am J Kidney Dis 2004; 43: 1-9. Go to original source... Go to PubMed...
  42. Birck R, Krzossok S, Markowetz F, Schnulle P, van der Woude FJ, Braun C. Acetylcysteine for prevention of contrast nephropathy: Meta-analysis. Lancet 2003; 362(9384): 598-603. Go to original source... Go to PubMed...
  43. Briguori C, Colombo A, Airoldi F, et al. N-acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity. J Am Coll Cardiol 2004; 44: 762-765. Go to original source... Go to PubMed...
  44. Ochoa A, Pellizzon G, Addala S, et al. Abbreviated dosing of N-acetylcysteine prevents contrast-induced nephropathy after elective and urgent coronary angiography and intervention. J Interven Cardiol 2004; 17: 159-165. Go to original source... Go to PubMed...
  45. Recio-Mayoral A, Chaparro, M, Prado B, et al. The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention. The RENO Study. J Am Coll Cardiol 2007; 49: 1283-1288. Go to original source... Go to PubMed...
  46. Briguori C, Airoldi F, D'Andrea D, et al. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 2007; 115: 1211-1217. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.